STI Technologies Limited offers intelligent reimbursement card solutions and related programs to the Canadian healthcare market, including drug sampling, medical device reimbursement, patient assistance, and patient choice programs. Its innoviCares card-based drug benefit program lets cardholders elect to stay on off-patent branded medication at little or no additional cost and can be used at any Canadian pharmacy. The innoviCares card is obtainable online at www.innovicares.ca or through physicians, local pharmacies, or employers, and the program includes 49 branded, off-patent medications such as Crestor, Celexa, Nexium, and Plavix. Founded in 2001 and led by CEO Steve Nicolle, the company now employs 50 people. The firm intends to use newly raised funds to further expand its services and reach into new areas of healthcare. The article does not disclose revenue or other operating metrics beyond headcount and program scope.

Total raised

$17M

Funding rounds

1

Latest round

Equity

Latest activity

Oct 2013